Our Team

Umer Raffat

  • Senior Managing Director
  • Equities
  • New York

Umer Raffat is a senior managing director at Evercore ISI and heads the large-cap therapeutics effort spanning pharmaceuticals-major and specialty pharmaceuticals.

As of 2023, Mr. Raffat has been ranked No. 1 on 19 separate occasions by Institutional Investor, starting from his first year covering the sector. Previously, he ranked as the No. 1 Rising Star Analyst for two years in a row. Most recently, he ranked No. 1 in both the biotechnology large-cap and specialty pharmaceuticals sectors, and No. 2 in major pharmaceuticals.

He started his equity research career under Dr. Mark Schoenebaum at Deutsche Bank in 2010, and they moved together to Evercore ISI.

In 2020, Mr. Raffat was inducted into Institutional Investor’s All-America Research Team Hall of Fame, a designation for analysts who have earned a No. 1 ranking on at least 10 occasions.

Mr. Raffat has an undergraduate degree in biology from University of Texas at Arlington and a master’s from Harvard School of Public Health.